Differential expression, localization and activity of MARCKS between mantle cell lymphoma and chronic lymphocytic leukemia
Open Access
- 23 September 2016
- journal article
- letter
- Published by Springer Nature in Blood Cancer Journal
- Vol. 6 (9) , e475
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Oncogenic microRNA-155 and its target PU.1: an integrative gene expression study in six of the most prevalent lymphomasInternational Journal of Hematology, 2015
- Developing Molecular Signatures for Chronic Lymphocytic LeukemiaPLOS ONE, 2015
- Flow Cytometric Analysis of Lymphoid Enhancer-Binding Factor 1 in Diagnosis of Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaAmerican Journal of Clinical Pathology, 2015
- Flow cytometric analysis of SOX11: a new diagnostic method for distinguishing B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma from mantle cell lymphomaLeukemia & Lymphoma, 2014
- Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individualsLeukemia, 2007
- From Gene Expression Analysis to Tissue MicroarraysMolecular & Cellular Proteomics, 2006
- Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profilingBlood, 2005
- The MARCKS family of phospholipid binding proteins: regulation of phospholipase D and other cellular componentsBiochemistry and Cell Biology, 2004
- Atypical chronic lymphocytic leukaemia witht(ll;14)(ql3;q32): karyotype evolution and prolymphocytic transformationBritish Journal of Haematology, 1995
- MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium–calmodulinNature, 1992